568
Views
98
CrossRef citations to date
0
Altmetric
Review

Multiplexing molecular diagnostics and immunoassays using emerging microarray technologies

, &
Pages 87-98 | Published online: 09 Jan 2014

References

  • Ross JS, Ginsburg GS. Integration of molecular diagnostics with therapeutics: implications for drug discovery and patient care. Expert Rev. Mol. Diagn.2, 531–541 (2002).
  • Jain KK. Applications of biochips: from diagnostics to personalized medicine. Curr. Opin. Drug Discov. Devel.2004, 7285–7289 (2004).
  • Chang CY, Silverman DH. Accuracy of early diagnosis and its impact on the management and course of Alzheimer’s disease. Expert Rev. Mol. Diagn.4, 63–69 (2004).
  • McLeod HL, Evans WE. Pharmacogenomics: unlocking the human genome for better drug therapy. Annu. Rev. Pharmacol. Toxicol.41, 101–121 (2001).
  • Wild D. The Immunoassay Handbook (third edition). Wild D (Ed.). Elsevier, Amsterdam, The Netherlands (2005).
  • Engvall E, Perlmann P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry8, 871–874 (1971).
  • Peruski AH, Peruski LF Jr. Immunological methods for detection and identification of infectious disease and biological warfare agents. Clin. Diagn. Lab. Immunol.10, 506–513 (2003).
  • Ford A. Move to integrated analyzers well underway. Cap. Today June, 14–48 (2006).
  • Mullis K. Dancing Naked in the Mind Field. Pantheon Books, NY, USA (1998).
  • Robinson WH, DiGennaro C, Hueber W et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med.8, 295–301 (2002).
  • Ewis AA, Zhelev Z, Bakalova R et al. A history of microarrays in biomedicine Expert Rev. Mol. Diagn.5, 315–328 (2005).
  • Nambiar S, Mirmohammadsadegh A, Bar A, Bardenheuer W, Roeder G, Hengge UR. Applications of array technology: melanoma research and diagnosis. Expert Rev. Mol. Diagn.4, 549–557 (2004).
  • Bustin SA, Dorudi S. Gene expression profiling for molecular staging and prognosis prediction in colorectal cancer. Expert Rev. Mol. Diagn.4, 599–607 (2004).
  • Hueber W, Utz PJ, Steinman L, Robinson WH. Autoantibody profiling for the study and treatment of autoimmune disease. Arthritis Res.4(5), 290–295 (2002).
  • Uttamchandani M, Wang J, Yao SQ. Protein and small molecule microarrays: powerful tools for high-throughput proteomics Mol. Biosyst.2(1), 58–68 (2006).
  • Zhu H, Snyder M. Protein chip technology. Curr. Opin. Chem. Biol.7(1), 55–63 (2003).
  • Strom CM. Mutation detection, interpretation, and applications in the clinical laboratory setting. Mutat. Res.573, 160–167 (2005)
  • Opalka D, Lachman CE, MacMullen SA et al. Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay. Clin. Diagn. Lab. Immunol.10, 108–15 (2003).
  • Ewart T, Carmichael S, Lea P. High quality epoxysilane substrate for clinical multiplex serodiagnostic proteomic microarrays Proc. SPIE5969, 59690I (2005).
  • Schena M. Protein Microarrays. Jones and Bartlett, Sudbury, MA, USA, 469 (2005).
  • Ekins RP, Chu F, Biggart E. The development of microspot multianalyte radiometric immunoassay using dual fluorescent labeled antibodies. Anal. Chim. Acta227, 73–90 (1990).
  • Bonfield TL, John N, Barna BP, Kavuru MS, Thomassen MJ, Yen-Lieberman B. Multiplexed particle-based anti-granulocyte macrophage colony stimulating factor assay used as pulmonary diagnostic test. Clin. Diagn. Lab. Immunol.12, 821–824 (2005).
  • Chen J, Iannone MA, Li MS et al. A microsphere-based assay for multiplexed single nucleotide polymorphism analysis using single base chain extension. Genome Res.10, 549–557 (2000).
  • Ekins RP. Ligand assays: from electrophoresis to miniaturized microarrays. Clin. Chem.44, 2015–2030 (1998).
  • Tonkinson JL, Osborn DS, Stillman BA, Zhao W. Assay Development – smaller is better-developing microscale immunoassays for parallel analysis of multiple analytes. IVD Technol.9(2) (2003).
  • Cazacu AC, Greer J, Taherivand M, Demmler GJ. Comparison of lateral-flow immunoassay and enzyme immunoassay with viral culture for rapid detection of influenza virus in nasal wash specimens from children. J. Clin. Microbiol.41, 2132–2134 (2003).
  • Saviranta P, Okon R. Brinker A, Warashina M, Eppinger J, Geierstanger BH. Evaluating sandwich immunoassays in microarray format in terms of the ambient analyte regime. Clin. Chem.50(10), 1907–1920 (2004).
  • Pawlak M, Schick E, Bopp MA, Schneider MJ, Oroszlan P, Ehrat M. Zeptosens’ protein microarrays: a novel high performance microarray platform for low abundance protein analysis. Proteomics2(4), 383–393 (2002).
  • Varnum SM, Warner MG, Dockendorff BP et al. Enzyme-amplified protein micorarray and a fluidic renewable surface fluorescence immunoassay for botulinum neurotoxin detection using high-affinity recombinant antibodies. Anal. Chim. Acta570, 137–143 (2006).
  • Arya M, Shergill IS, Williamson M et al. Basic principles of real-time quantitative PCR Expert Rev. Mol. Diagn.5, 209–219 (2005).
  • Alessandri C, Bombardieri M, Papa N et al. Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement. Ann. Rheum. Dis.63(10), 1218–1221 (2004).
  • Schellekens GA, Visser H, de Jong BA. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum.43, 155–163 (2000).
  • Anthony RM, Brown TJ, French GL. DNA array technology and diagnostic microbiology. Expert Rev. Mol. Diagn.1, 30–38 (2001).
  • Toder R. DNA arrays as diagnostic tools in human healthcare. Expert Rev. Mol. Diagn.2, 422–428 (2002).
  • Class II Special Controls Guidance Document. Instrumentation for Clinical Multiplex Test Systems. Document issued on: 10 March (2005).
  • Draft Guidance for Industry and FDA Staff-Commercially Distributed Analyte Specific Reagents (ASRs): frequently asked questions. Document issued on: 7 September (2006).
  • Guidance for Industry-Analyte Specific Reagents; Small Entity Compliance Guidance. Document issued on: 26 February (2003).
  • Henrickson KJ. Cost-effective use of rapid diagnostic techniques in the treatment and prevention of viral respiratory infections. Pediatr. Ann.34(1), 24–31 (2005).
  • Yang S, Rothman RE. PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings. Lancet Infect. Dis.4(6), 337–348 (2004).
  • Perrin A, Duracher D, Perret M, Cleuziat P, Mandrand B. A combined oligonucleotide and protein microarray for the codetection of nucleic acids and antibodies associated with human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infections. Anal. Biochem.322, 148–155 (2003).
  • Situma C, Hashimoto M, Soper SA. Merging microfluidics with microarray-based bioassays. Biomol. Eng.23(5), 213–231 (2006).

Websites

  • Cystic Fibrosis Mutation Database. Cystic Fibrosis Consortium www.genet.sickkids.on.ca/cftr (Accessed May 2005)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.